Related Experiment Video
Updated: Jul 24, 2026

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
Published on: April 15, 2014
Potential clinical uses of neuroactive steroids
C F Zorumski1, S Mennerick, K E Isenberg
1Department of Psychiatry, Washington University School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA. zorumskc@psychiatry.wustl.edu
Neuroactive steroids modulate brain receptors, offering potential treatments for neurological and psychiatric disorders. Advances in drug development suggest clinical applications for these compounds are promising.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Neuroactive steroids rapidly influence gamma-aminobutyric acid (GABA) and glutamate receptors in the central nervous system.
- GABA-enhancing neurosteroids show potential for anesthetic, hypnotic, anticonvulsant, and anxiolytic applications.
- These neurosteroids may also play a role in mood regulation and the neurological effects of alcohol, indicating relevance to psychiatric disorders.
Purpose of the Study:
- To explore the clinical potential of neuroactive steroids.
- To highlight the therapeutic possibilities of modulating GABA and glutamate receptors with neurosteroids.
- To discuss the implications for treating neurological and psychiatric conditions.
Main Methods:
- The abstract does not specify methods but discusses the known mechanisms of neuroactive steroids.
- Focuses on the receptor modulation (GABA and glutamate) by neuroactive steroids.
- Reviews the potential therapeutic applications based on these mechanisms.
Main Results:
- GABA-enhancing steroids have demonstrated potential as anesthetics, hypnotics, anticonvulsants, and anxiolytics.
- Neuroactive steroids targeting glutamate receptors may be beneficial for neurodegenerative disorders and cognitive enhancement.
- The role of GABAergic neurosteroids in mood regulation and alcohol's effects suggests involvement in psychiatric disorders.
Conclusions:
- Neuroactive steroids offer diverse therapeutic possibilities for a range of neurological and psychiatric conditions.
- Development of water-soluble and orally effective neurosteroids enhances the likelihood of clinical translation.
- Further research and development hold promise for the clinical use of specific neuroactive steroids.
More Related Videos
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
07:47A Protocol For Uncovering Neural Mechanisms Of Neurotherapeutic Effects On Electroencephalography Using The Human Neocortical Neurosolver
Published on: May 19, 2026
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Drugs Affecting Neurotransmitter Synthesis
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists